Revisión bibliográfica: Estado actual de investigación sobre la psilocibina y su efecto en los trastornos mentales
| dc.contributor.advisor | García Rincón, Eliana Graciel | |
| dc.contributor.author | Hernandez Lancheros, Jhon Sebastian | |
| dc.contributor.cvlac | García Rincón, Eliana Graciela [0000135069] | spa |
| dc.coverage.campus | UNAB Campus Bucaramanga | spa |
| dc.coverage.spatial | San Gil (Santander, Colombia) | spa |
| dc.coverage.temporal | 2025 | spa |
| dc.date.accessioned | 2025-12-01T13:25:53Z | |
| dc.date.available | 2025-12-01T13:25:53Z | |
| dc.date.issued | 2025-11-19 | |
| dc.degree.name | Psicólogo | spa |
| dc.description.abstract | El presente proyecto de grado tuvo como propósito analizar la relación entre el uso de la psilocibina y el tratamiento de los trastornos mentales a través de una revisión Bibliográfica de la literatura científica disponible. A partir del examen de diversas fuentes académicas, se evidenció que la psilocibina ha mostrado resultados prometedores en el manejo de afecciones como la depresión resistente, la ansiedad y el trastorno por consumo de sustancias, al favorecer experiencias terapéuticas que promueven la introspección, la regulación emocional y la reconexión con el sentido vital. Sin embargo, también se identificaron riesgos potenciales asociados a su uso, como la posibilidad de crisis psicológicas o reactivación de traumas, lo que subraya la necesidad de aplicar protocolos clínicos rigurosos y acompañamiento profesional. En el contexto colombiano, el interés por esta línea de investigación se encuentra en crecimiento, aunque aún enfrenta limitaciones legales y científicas que restringen su aplicación práctica. Este trabajo resalta la importancia de continuar explorando el potencial terapéutico de la psilocibina desde una perspectiva ética, humanizada y basada en evidencia, que priorice la seguridad y el bienestar integral de las personas. | spa |
| dc.description.abstractenglish | This undergraduate research project aimed to analyze the relationship between the use of psilocybin and the treatment of mental disorders through a Literature review of the available scientific literature. Based on the examination of various academic sources, the findings revealed that psilocybin has shown promising results in managing conditions such as treatment-resistant depression, anxiety, and substance use disorders, as it facilitates therapeutic experiences that promote introspection, emotional regulation, and reconnection with personal meaning. However, potential risks were also identified, including the possibility of psychological crises or the reactivation of past traumas, emphasizing the need for rigorous clinical protocols and professional guidance. In the Colombian context, interest in this field of study is increasing, although it still faces legal and scientific limitations that restrict its practical application. This work highlights the importance of continuing to explore the therapeutic potential of psilocybin from an ethical, humanized, and evidence-based perspective that prioritizes safety and the overall well-being of individuals. | spa |
| dc.description.degreelevel | Pregrado | spa |
| dc.description.learningmodality | Modalidad Presencial | spa |
| dc.description.sponsorship | Fundación Universitaria de San Gil UNISANGIL | spa |
| dc.description.tableofcontents | Introducción 8 Planteamiento del Problema 9 Justificación 10 Objetivos 11 Objetivo General 11 Objetivos Específicos 11 Marcos De Referencia 11 Marco Conceptual 11 Marco Contextual 15 Marco Legal 16 Marco Metodológico 19 Diseño Y Tipo De Investigación 19 Unidad de Análisis 19 Procedimiento 20 Resultados 22 Discusión 34 Conclusiones 35 Recomendaciones 38 Referencias Bibliográficas 41 | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga - UNAB | spa |
| dc.identifier.reponame | reponame:Repositorio Institucional UNAB | spa |
| dc.identifier.repourl | repourl:https://repository.unab.edu.co | spa |
| dc.identifier.uri | http://hdl.handle.net/20.500.12749/32341 | |
| dc.language.iso | spa | spa |
| dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
| dc.publisher.grantor | Universidad Autónoma de Bucaramanga UNAB | spa |
| dc.publisher.program | Pregrado Psicología | spa |
| dc.publisher.programid | PSI-265 | |
| dc.relation.references | Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J. (2018). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology, 235(2), 399–408. https://doi.org/10.1007/s00213-017-4771-x | spa |
| dc.relation.references | Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial: A randomized clinical trial. JAMA Psychiatry (Chicago, Ill.), 78(5), 481–489. | spa |
| dc.relation.references | De, M. (s/f). Boletín de salud mental Depresión Subdirección de Enfermedades No Transmisibles. Gov.co. Recuperado el 9 de mayo de 2023, de https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/boletind epresion-marzo-2017.pdf. | spa |
| dc.relation.references | Escohotado, A. (2002). Aprendiendo de las drogas, Usos y abusos, prejuicios y desafíos. Recuperado el 10 de mayo de 2023, de https://www.edu.xunta.gal/centros/iesmontecastelo/system/files/Antonio+Escohotado+- +Aprendiendo+de+las+drogas.pdf. | spa |
| dc.relation.references | OPS. (2022). Salud en las américas 2022. Panorama de la Región de las Américas en el contexto de la pandemia de COVID-19. Recuperado el 9 de mayo de 2023, de https://iris.paho.org/bitstream/handle/10665.2/56471/OPASEIHHA220024_spa.pdf?sequ ence=5&isAllowed=y. Pérez Esparza, Rodrigo. (2017). Tratamiento farmacológico de la depresión: actualidades y futuras direcciones. Revista de la Facultad de Medicina (México), 60(5), 7-16. Recuperado en 09 de mayo de 2023, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026- 17422017000500007&lng=es&tlng=es. | spa |
| dc.relation.references | Bimonte Gonzalo. (2022). Psicología transpersonal y psicodélicos: recorrido histórico sobre la influencia de las experiencias místicas en la disciplina psicológica [en línea]. Trabajo final de grado. Montevideo: Udelar.FP. https://www.colibri.udelar.edu.uy/jspui/bitstream/20.500.12008/36278/1/psicologia_transpersona l_y_psicodelicos_tfg_gonzalo_bimonte.pdf. | spa |
| dc.relation.references | Breitbart W. (2002). Spirituality and meaning in supportive care: spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 10(4), 272–280. https://doi.org/10.1007/s005200100289 | spa |
| dc.relation.references | Brown, S., Rittenbach, K., Cheung, S., McKean, G., MacMaster, F. P., & Clement, F. (2019). Current and common definitions of treatment-resistant depression: Findings from a systematic review and qualitative interviews. Canadian Journal of Psychiatry, 64(6), 380-387. | spa |
| dc.relation.references | Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Pilling, S., Curran, V. H., & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The lancet. Psychiatry, 3(7), 619–627. https://doi.org/10.1016/S2215-0366(16)30065-7 Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., | spa |
| dc.relation.references | Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J. (2018). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology, 235(2), 399–408. https://doi.org/10.1007/s00213-017-4771-x | spa |
| dc.relation.references | Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402-1411. | spa |
| dc.relation.references | Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., ... Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. | spa |
| dc.relation.references | Davis, A. K., Barrett, F. S., May, D. G., et al. (2021). Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285 | spa |
| dc.relation.references | García, G. (2023, 6 de febrero). Australia aprueba el uso de la psilocibina y la MDMA para el tratamiento de enfermedades mentales.Guiasdelpsiconauta.news. https://guiasdelpsiconauta.news/blog/2023/02/06/australia-aprueba-usar-mdma-psilocibina/ | spa |
| dc.relation.references | Gukasyan, N., Davis, A. K., Barrett, F. S., et al. (2022). Eficacia y seguridad del tratamiento asistido con psilocibina para el trastorno depresivo mayor: seguimiento prospectivo de 12 meses. Revista de Psicofarmacología, 36(2), 151-158. https://doi.org/10.1177/02698811211073759 | spa |
| dc.relation.references | Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M. (2021). Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proceedings of the National Academy of Sciences of the United States of America, 118(17), e2022489118. https://doi.org/10.1073/pnas.2022489118 | spa |
| dc.relation.references | Nichols DE. Psilocybin: from ancient magic to modern medicine. J Antibiot. 2020;73(10):679-86. https://doi. org/10.1038/s41429-020-0311-8 | spa |
| dc.relation.references | Faccini-Durán G. Apuntes sobre filogénesis del sistema nervioso y la conciencia. Acta Neurol Colomb. 2024;40(1). https://doi.org/10.22379/anc.v40i1.823 | spa |
| dc.relation.references | Xing L, Kalebic N, Namba T, Vaid S, Wimberger P, Huttner WB. Serotonin receptor 2A activation promotes evolutionarily relevant basal progenitor proliferation in the developing neocortex. Neuron. 2020;108(6):1113-29.e6. https:// doi.org/10.1016/j.neuron.2020.09.034 | spa |
| dc.relation.references | Beliveau V, Ganz M, Feng L, Ozenne B, Højgaard L, Fisher PM, et al. A high-resolution in vivo atlas of the human brain's serotonin system. J Neurosci. 2017;37(1):120-8. https://doi.org/10.1523/jneurosci.2830-16.2016 | spa |
| dc.relation.references | Casanova AF, Ort A, Smallridge JW, Preller KH, Seifritz E, Vollenweider FX. The influence of psilocybin on subconscious and conscious emotional learning. iScience. 2024;27(6):110034. https://doi.org/10.1016/j.isci.2024.110034 | spa |
| dc.relation.references | Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G. Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder. Front Psychiatry. 2024;15:1406888. https://doi.org/10.3389/fpsyt.2024.1406888 | spa |
| dc.relation.references | Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatmentresistant episode of major depression. N Engl J Med. 2022;387(18):1637-48. https://doi.org/10.1056/nejmoa2206443 | spa |
| dc.relation.references | Deco G, Sanz Perl Y, Johnson S, Bourke N, Carhart-Harris RL, Kringelbach ML. Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression. Nat Ment Health. 2024;2(9):1096-110. https://doi. org/10.1038/s44220-024-00298-y | spa |
| dc.relation.references | Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11(1):574. https://doi.org/10.1038/ s41398-021-01706- | spa |
| dc.relation.references | Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181-97. https://doi.org/10.1177/0269881116675513 | spa |
| dc.relation.references | Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, et al. Efficacy and safety of psilocybinassisted treatment for major depressive disorder: prospective 12-month follow-up. J Psychopharmacol. 2022;36(2):151- 8. https://doi.org/10.1177/02698811211073759 16. Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, et al. Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial. Sci Rep. 2024;14(1):8833. https://doi.org/10.1038/s41598-024-58318-x | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.creativecommons | Atribución-NoComercial-SinDerivadas 2.5 Colombia | * |
| dc.rights.local | Abierto (Texto Completo) | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | * |
| dc.subject.keywords | Psilocybin | spa |
| dc.subject.keywords | Psychology | spa |
| dc.subject.keywords | Therapy | spa |
| dc.subject.keywords | Mental health | spa |
| dc.subject.keywords | Mental disorders | spa |
| dc.subject.keywords | Information recovery | spa |
| dc.subject.keywords | Bibliographic search | spa |
| dc.subject.keywords | Psychology pathological | spa |
| dc.subject.keywords | Psychotropic plants | spa |
| dc.subject.keywords | Antidepressants | spa |
| dc.subject.lemb | Psicología | spa |
| dc.subject.lemb | Recuperación de información | spa |
| dc.subject.lemb | Búsqueda bibliográfica | spa |
| dc.subject.lemb | Psicopatología | spa |
| dc.subject.lemb | Plantas psicotrópicas | spa |
| dc.subject.lemb | Antidepresivos | spa |
| dc.subject.proposal | Psilocibina | spa |
| dc.subject.proposal | Terapia | spa |
| dc.subject.proposal | Trastornos mentales | spa |
| dc.subject.proposal | Salud mental | spa |
| dc.title | Revisión bibliográfica: Estado actual de investigación sobre la psilocibina y su efecto en los trastornos mentales | spa |
| dc.title.translated | Literature review: Current state of research on psilocybin and its effect on mental disorders | spa |
| dc.type | Bachelor tesis | eng |
| dc.type.coar | http://purl.org/coar/resource_type/c_7a1f | |
| dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
| dc.type.driver | info:eu-repo/semantics/bachelorThesis | spa |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Trabajo de Grado | spa |
| dc.type.redcol | http://purl.org/redcol/resource_type/TP |
Archivos
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 829 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción:
